Zipnosis Raises $3 Million in Funding for Telemedicine Tools

August 30, 2018  Source: MobiHealthNews 876

"/

Zipnosis specializes in offering telemedicine tools to providers in order to launch their own telemedicine services, whereas other telemedicine companies offer services either directly or via health insurers.

Last week, Zipnosis raised $3 million through funding, which led to a total of up to $23 million due to existing investors like Safeguard Scientifics and Ascension Ventures among others.

Jon Pearce, the CEO of Zipnosis said, “As an organization focused on sustainable, organic growth, we were very intentional about the size of our Series B. In this industry, you hear about huge amounts of cash being splashed around. Zipnosis didn’t require a massive infusion of investment to achieve our growth objectives. It was more important for us to take precisely what we needed to move to the next level – no more and no less.”

In January, Zipnosis teamed up with Methodist Family Health Centers, to unveil an online diagnosis and treatment service named Methodist NOW and in February they launched Patient Outreach, which aids hospitals in patient visits.

In April, Zipnosis teamed up with The American Academy of Family Physicians to provide an online diagnosis and treatment system followed by the addition of post-surgical care.

Lastly, in June, they announced the expanded Surescripts certification to add medication history into patients’ data available to telemedicine doctors. 

Jon Pearce further added, “We absolutely believe that healthcare is still local and we believe that it’s the long-term and the right solution not only for the best quality care but also for the most affordable care for patients. The healthcare providers haven’t moved quick enough. The incentives haven’t been there and change is hard in healthcare.”

By Ddu
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.